-
-
-
-
-
-
-
Lantern Pharma appoints Dr. Lee Schalop to board of directors
-
-
-
-
-
-
-
Lantern Pharma Announces Extension of Existing Share Repurchase Program
-
-
-
-
-
-
-
Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging Agent
1,199,265 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


